Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 3/20 | 0.64 |
| ▸ | ZDHHC2 | Q9UIJ5 | 2/20 | 0.64 |
| ▸ | EPHX1 | P07099 | 10/20 | 0.58 |
| ▸ | CASP2 | P42575 | 1/20 | 0.52 |
| ▸ | EGFR | P00533 | 1/20 | 0.49 |
| ▸ | NAAA | Q02083 | 1/20 | 0.48 |
| ▸ | ADH1B | P00325 | 1/20 | 0.48 |
| ▸ | ADH1C | P00326 | 1/20 | 0.48 |
| ▸ | ADH1A | P07327 | 1/20 | 0.48 |
| ▸ | ADH4 | P08319 | 1/20 | 0.48 |
| ▸ | ADH7 | P40394 | 1/20 | 0.48 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13645782 | 0.98 | ZDHHC20 (0.68) | ZDHHC20ZDHHC2EPHX1CASP2EGFR | |
| SCHEMBL4850657 | 0.98 | ZDHHC20 (0.68) | ZDHHC20ZDHHC2EPHX1CASP2EGFR | |
| SCHEMBL14332259 | 0.98 | ZDHHC20 (0.68) | ZDHHC20ZDHHC2EPHX1CASP2EGFR | |
| SCHEMBL23505654 | 0.98 | ZDHHC20 (0.68) | ZDHHC20ZDHHC2EPHX1CASP2EGFR | |
| SCHEMBL23505697 | 0.98 | ZDHHC20 (0.68) | ZDHHC20ZDHHC2EPHX1CASP2EGFR | |
| SCHEMBL4855765 | 0.93 | — | — | |
| SCHEMBL535450 | 0.83 | — | — | |
| SCHEMBL5362502 | 0.82 | ZDHHC20 (0.70) | ZDHHC20ZDHHC2EPHX1CASP2EGFR | |
| SCHEMBL6131120 | 0.82 | ZDHHC20 (0.70) | ZDHHC20ZDHHC2EPHX1CASP2EGFR | |
| SCHEMBL444526 | 0.82 | ZDHHC20 (0.70) | ZDHHC20ZDHHC2EPHX1CASP2EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200190165-A1 | COMPOUND HAVING AFFINITY SUBSTANCE TO SOLUBLE PROTEIN, CLEAVABLE PORTION AND REACTIVE GROUP, OR SALT THEREOF | AJINOMOTO CO., INC. (JP) | 2020-06-18 | — | — | US | disclosed |
| US-7355074-B2 | Compounds having aromatic rings and side-chain amide-functionality and a method for transporting monovalent anions across biological membranes using the same | THE UNIVERSITY OF MARYLAND (US) | 2008-04-08 | — | — | US | disclosed |
| US-20050009921-A1 | Compounds having aromatic rings and side-chain amide-functionality and a method for transporting monovalent anions across biological membranes using the same | MARYLAND, UNIVERSITY OF | 2005-01-13 | — | — | US | disclosed |
| US-6225334-B1 | AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2001-05-01 | — | — | US | disclosed |
| US-5221762-A | Reacting a phenol with benzolactone compound; then phosgene or thionyl chloride; esterification with alcohol | BASF AKTIENGESELLSCHAFT (DE) | 1993-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200190165-A1 | COMPOUND HAVING AFFINITY SUBSTANCE TO SOLUBLE PROTEIN, CLEAVABLE PORTION AND REACTIVE GROUP, OR SALT THEREOF | SPPL2B, CSTB, SPPL2A | ZDHHC20 3644/4885ZDHHC2 4198/4885EPHX1 2765/4885 |
| US-20050009921-A1 | Compounds having aromatic rings and side-chain amide-functionality and a method for transporting monovalent anions across biological membranes using the same | SLC26A3, SLC22A8, SLC43A1 | ZDHHC20 427/4885ZDHHC2 449/4885EPHX1 2121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.